CBOE

Franklin Genomic Advancements ETF (HELX)

♥ 575 Thanks from members

Live price chart, market sentiment, and community perspectives for Franklin Genomic Advancements ETF (CBOE: HELX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Financial ServicesIndustry: Exchange Traded FundFounder: Franklin TempletonLeadership: Jenny Johnson (CEO)Holder: Franklin ResourcesHolder: Institutional InvestorsFranklin Genomic Advancements ETF Portfolio#HELX#Franklin Templeton ETF#genomics ETF#biotech investing#CBOE:HELX